Ehlers-Danlos Syndrome Clinical Trials

5 recruiting

Ehlers-Danlos Syndrome Trials at a Glance

10 actively recruiting trials for ehlers-danlos syndrome are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Belém, Belo Horizonte, and Bologna. Lead sponsors running ehlers-danlos syndrome studies include Andres Schanzer, Baylor College of Medicine, and Acer Therapeutics Inc..

Browse ehlers-danlos syndrome trials by phase

Treatments under study

About Ehlers-Danlos Syndrome Clinical Trials

Looking for clinical trials for Ehlers-Danlos Syndrome? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ehlers-Danlos Syndrome trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ehlers-Danlos Syndrome clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Metabolic Phenotyping in vEDS

Vascular Ehlers-Danlos Syndrome
Cambridge University Hospitals NHS Foundation Trust15 enrolled1 locationNCT07516496
Recruiting
Not Applicable

Auricular Vagal Nerve Stimulation for Hypermobile Ehlers-Danlos Syndrome

Functional Gastrointestinal DisordersHypermobile Ehlers-Danlos Syndrome
Medical College of Wisconsin90 enrolled1 locationNCT05212129
Recruiting

National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry

Sudden Cardiac DeathArrhythmogenic Right Ventricular DysplasiaCardiomyopathy, Dilated+11 more
Hospital do Coracao600 enrolled27 locationsNCT06546137
Recruiting

Registry of Ehlers-Danlos Syndrome

Ehlers-Danlos Syndrome
Luca Sangiorgi3,000 enrolled1 locationNCT04133272
Recruiting
Not Applicable

Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices

Ehlers-Danlos SyndromeComplex Aortic AneurysmsThoracoabdominal Aneurysms+5 more
Andres Schanzer600 enrolled1 locationNCT02050113
Recruiting
Phase 3

Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome

Vascular Ehlers-Danlos Syndrome
Acer Therapeutics Inc.150 enrolled1 locationNCT05432466
Recruiting

Autonomic Small Fiber Neuropathy and Ehlers Danlos Syndromes - Prospective Study and Registry

Small Fiber NeuropathyPostural Tachycardia SyndromeAutonomic Neuropathy+1 more
RWTH Aachen University200 enrolled1 locationNCT04310644
Recruiting

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

Myasthenia GravisAmyloidosisAlpha-Thalassemia+14 more
xCures1,000 enrolled1 locationNCT06539169
Recruiting
Not Applicable

Heart Coherence Training on Vascular Ehlers-Danlos Syndrome Patients

Vascular Ehlers-Danlos Syndrome
Baylor College of Medicine40 enrolled1 locationNCT05994664
Recruiting
Not Applicable

Light Exposure on Pain in Hypermobile Ehlers-Danlos Syndrome

Pain, ChronicEhlers-Danlos Syndrome
New York Institute of Technology30 enrolled1 locationNCT05561270